JAK2 and IDH Combination Therapy

Here’s a new research article pertaining to JAK2 and IDH- mutant driven MPN’s with indications that combined JAK and IDH inhibition may offer therapeutic advantages.

https://www.jci.org/articles/view/94516#.Wm5SC6FBXDw